Error
Jump to navigation
Jump to search
Subcategories
This category has the following 4 subcategories, out of 4 total.
Pages in category "Metabolic disorders"
The following 111 pages are in this category, out of 300 total.
(previous page) (next page)H
- High triglyceride life style modification
- Homocystinuria (patient information)
- Hunter syndrome (patient information)
- Hunter syndrome case study one
- Hurler syndrome (patient information)
- Hurler syndrome case study one
- Hurler syndrome classification
- Hyperglycemia
- Hyperinsulinemic hypoglycemia
- Hyperlipidemia historical perspective
- Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents
- Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents
- Hyperlipidemia primary prevention
- Hyperlipidemia secondary prevention
- Hyperlipidemia statins in children and adolescents with hyperlipidemia
- Hyperlipoproteinemia epidemiology and demographics
- Hyperlipoproteinemia laboratory findings
- Hyperlipoproteinemia medical therapy
- Hyperlipoproteinemia natural history, complications and prognosis
- Hyperlipoproteinemia physical examination
- Hyperpipecolatemia
- Hypertriglyceridemia chest x ray
- Hypertriglyceridemia differential diagnosis
- Hypertriglyceridemia niacin
- Hypertriglyceridemia omega-3 fatty acids
- Hypoglycemia differential diagnosis
- Causes of hypoglycemia
I
L
M
- Malonyl-CoA decarboxylase deficiency
- Maple syrup urine disease (patient information)
- Menkes disease
- Metab-L
- Metabolic syndrome differentiating metabolic syndrome from other diseases
- Mineralocorticoid resistant hyperkalemia
- Mucopolysaccharidosis (patient information)
- Muscle weakness
- Muscle weakness (patient information)
- Muscle weakness case study one
- Muscle weakness causes
- Muscle weakness chest x ray
- Muscle weakness classification
- Muscle weakness cost-effectiveness of therapy
- Muscle weakness CT
- Muscle weakness differential diagnosis
- Muscle weakness electrocardiogram
- Muscle weakness epidemiology and demographics
- Muscle weakness future or investigational therapies
- Muscle weakness historical perspective
- Muscle weakness history and symptoms
- Muscle weakness laboratory findings
- Muscle weakness medical therapy
- Muscle weakness MRI
- Muscle weakness natural history, complications and prognosis
- Muscle weakness other diagnostic studies
- Muscle weakness other imaging findings
- Muscle weakness overview
- Muscle weakness pathophysiology
- Muscle weakness physical examination
- Muscle weakness primary prevention
- Muscle weakness risk factors
- Muscle weakness screening
- Muscle weakness secondary prevention
N
O
P
S
- Salicylate sensitivity
- Secondary amyloidosis (patient information)
- Senile systemic amyloidosis
- Short-chain acyl-coenzyme A dehydrogenase deficiency
- Sitosterolemia
- Snoring (patient information)
- Stress hyperglycemia
- Sugar crash
- Syncope
- Syncope (patient information)
- Syncope case study one
- Syncope cost-effectiveness of therapy
- Syncope future or investigational therapies
- Syncope history and symptoms
- Syncope overview
- Syncope primary prevention
- Syncope secondary prevention
- Syncope surgery